BIONXT SOLUTIONS INC. (BXT) - Total Liabilities

Latest as of September 2025: €9.54 Million EUR ≈ $11.15 Million USD

Based on the latest financial reports, BIONXT SOLUTIONS INC. (BXT) has total liabilities worth €9.54 Million EUR (≈ $11.15 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does BIONXT SOLUTIONS INC. generate cash to assess how effectively this company generates cash.

BIONXT SOLUTIONS INC. - Total Liabilities Trend (2021–2024)

This chart illustrates how BIONXT SOLUTIONS INC.'s total liabilities have evolved over time, based on quarterly financial data. See BXT net assets for net asset value and shareholders' equity analysis.

BIONXT SOLUTIONS INC. Competitors by Total Liabilities

The table below lists competitors of BIONXT SOLUTIONS INC. ranked by their total liabilities.

Company Country Total Liabilities
JFB Construction Holdings Class A Common Stock
NASDAQ:JFB
USA $2.31 Million
Singulus Technologies AG
XETRA:SNG
Germany €109.60 Million
S P V I Public Company Limited
BK:SPVI
Thailand ฿710.10 Million
Goldspot Discoveries Corp
V:SPOT
Canada CA$11.40 Million
Pharmx Technologies Ltd
AU:PHX
Australia AU$2.90 Million
Modi Rubber Limited
NSE:MODIRUBBER
India Rs812.47 Million
First Graphene Ltd
F:M11
Germany €3.53 Million
Asia Metal Public Company Limited
BK:AMC
Thailand ฿2.52 Billion

Liability Composition Analysis (2021–2024)

This chart breaks down BIONXT SOLUTIONS INC.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BXT stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.15 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.78 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BIONXT SOLUTIONS INC.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BIONXT SOLUTIONS INC. (2021–2024)

The table below shows the annual total liabilities of BIONXT SOLUTIONS INC. from 2021 to 2024.

Year Total Liabilities Change
2024-12-31 €8.43 Million
≈ $9.86 Million
+28.71%
2023-12-31 €6.55 Million
≈ $7.66 Million
+14.10%
2022-12-31 €5.74 Million
≈ $6.71 Million
-28.75%
2021-12-31 €8.06 Million
≈ $9.42 Million
--

About BIONXT SOLUTIONS INC.

F:BXT Germany Drug Manufacturers - Specialty & Generic
Market Cap
$40.81 Million
€34.91 Million EUR
Market Cap Rank
#23111 Global
#2022 in Germany
Share Price
€0.29
Change (1 day)
+0.00%
52-Week Range
€0.27 - €0.67
All Time High
€2.28
About

BioNxt Solutions Inc. engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland. The company provides BNT23001for the treatment of multiple sclerosis; BNT23002 for the treatment of myasthenia gravis; BNT24002, a sublingual thin film for the treatment of lupus nephritis; BNT24003 for the treatment of rheum… Read more